RESPIRATORY MEDICINE

RESPIRATORY MEDICINE

RESP MED
影响因子:3.1
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:W.B. Saunders Ltd
发刊时间:1989
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:0954-6111

期刊介绍

Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.
《呼吸医学》是一本国际知名期刊,致力于快速发表与临床相关的呼吸医学研究。它结合了尖端的原创研究与最先进的审查处理呼吸系统疾病和治疗干预的各个方面。主题包括成人和儿科医学、流行病学、免疫学和细胞生物学、生理学、职业病以及过敏原和污染物的作用。呼吸医学越来越成为出版分阶段试验工作的首选杂志,对有效性、剂量和作用方法进行评论。
年发文量 281
国人发稿量 31.08
国人发文占比 0.11%
自引率 -
平均录取率0
平均审稿周期 平均3月
版面费 US$3320
偏重研究方向 医学-呼吸系统
期刊官网 http://www.journals.elsevier.com/respiratory-medicine/
投稿链接 https://www.editorialmanager.com/YRMED

期刊高被引文献

Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2018.11.012
Mepolizumab improves small airway function in severe eosinophilic asthma.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.01.016
Association between vitamin D status and asthma control: A meta-analysis of randomized trials.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.02.016
The role of evaluating inspiratory constraints and ventilatory inefficiency in the investigation of dyspnea of unclear etiology.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.09.007
The effect of carvacrol on inflammatory mediators and respiratory symptoms in veterans exposed to sulfur mustard, a randomized, placebo-controlled trial.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.01.020
Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2018.11.001
Clinical approach and review of causes of a chylothorax.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.08.014
A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6\u202fμg and 160/18/9.6\u202fμg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.08.010
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.08.006
A mesh nebulizer is more effective than jet nebulizer to nebulize bronchodilators during non-invasive ventilation of subjects with COPD: A randomized controlled trial with radiolabeled aerosols.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.05.016
Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.02.018
Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.06.025
Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.04.009
Acute exacerbation of interstitial lung disease after procedures.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.02.012
Efficacy and tolerability of desensitization in the treatment of delayed drug hypersensitivities to anti-tuberculosis medications.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2018.12.017
Severe asthma phenotypes in patients controlled with omalizumab: A real-world study.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.105804
Real-life inhaler adherence and technique: Time to get smarter!
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.09.008
Real-life comparison of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis: A 24-month assessment.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.105803
Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.06.016
Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.04.021
The development of sarcoidosis in patients receiving daclizumab: A case series from multiple clinical trials.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.01.015
One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β2-agonist in UK primary care settings.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.105859
A new postural device for the treatment of positional obstructive sleep apnea. A pilot study.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.02.005
Eosinophilic airway inflammation is a main feature of unstable asthma in adolescents.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2018.12.009
Clinical characteristics and etiologies of bronchiectasis in Korean children: A multicenter retrospective study.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.01.018
Efficacy and safety of tigecycline for Mycobacterium abscessus disease.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.10.006
Ultra-LABAs for the treatment of asthma.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.08.005
Impact of a homeopathic medication on upper respiratory tract infections in COPD patients: Results of an observational, prospective study (EPOXILO).
来源期刊:Respiratory MedicineDOI:10.1016/J.RMED.2018.11.011
Trends over time in COPD treatment choices by respiratory physicians: An analysis from the COLIBRI-COPD French cohort.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.07.023
Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients?
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.01.001
A systematic map and in-depth review of European telehealth interventions efficacy for chronic obstructive pulmonary disease.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.09.005
High ACT score is not sufficient to reduce the risk of asthma exacerbations in asthma with low lung function.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.02.010
Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2018.12.006
Hospitalizations with hereditary hemorrhagic telangiectasia and pulmonary hypertension in the United States from 2000 to 2014.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2018.12.013
The natural course of lung function decline in asbestos exposed subjects with pleural plaques and asbestosis.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.06.013
Adverse cardiac outcomes after pulmonary function testing with recent myocardial infarction.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.07.003
Utility of fiber-optic bronchoscopy in pulmonary infections among abdominal solid-organ transplant patients: A comprehensive review.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2018.12.002
Correlation of spirometry and body plethysmography during exercise-induced bronchial obstruction.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.01.011
Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2018.11.020
Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.06.019
Effect of smoking status on lung function, patient-reported outcomes, and safety among patients with COPD treated with indacaterol/glycopyrrolate: Pooled analysis of the FLIGHT1 and FLIGHT2 studies.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.07.019
CAT score single item analysis in patients with COPD: Results from COSYCONET.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.105810
Low socioeconomic position and neighborhood deprivation are associated with uncontrolled asthma in elderly.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.09.010
The minimal detectable difference for endurance shuttle walk test performance in people with COPD on completion of a program of high-intensity ground-based walking.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2018.11.013
Lung function deterioration predicts elevated troponin levels in apparently healthy individuals throughout a 5-year follow-up.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.05.021
Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.06.010
All-cause and cause-specific mortality from restrictive and obstructive spirometric patterns in Chinese adults with and without dyspnea: Guangzhou Biobank Cohort Study.
来源期刊:Respiratory medicineDOI:10.1016/J.RMED.2019.04.002
Predictive and modifying factors of bone mineral density decline in patients with COPD.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.01.005
Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.105816
Role of thoracic imaging in the management of lymphangioleiomyomatosis.
来源期刊:Respiratory medicineDOI:10.1016/j.rmed.2019.08.013

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
94.31%28.89%-0.85%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
CARDIAC & CARDIOVASCULAR SYSTEMS
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区
RESPIRATORY SYSTEM 呼吸系统
3区
2023年12月升级版
医学3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区
RESPIRATORY SYSTEM 呼吸系统
3区
2022年12月旧的升级版
医学3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区
RESPIRATORY SYSTEM 呼吸系统
3区